Aspergillosis is the name given to the spectrum of diseases caused by the genus Aspergillus. Research on aspergillosis has shown a progressive expansion over the past decades, largely due to the rise in the number of immunocompromised individuals who are at risk for the infection. Nanotechnology provides innovative tools in the medicine, diagnosis, and treatment. The unique properties of nanomaterials like small size in the nanoscale have attracted researchers to explore their potential, especially in medical diagnostics. Aptamers, considered as chemical antibody, are short, single-stranded oligonucleotide molecules with high affinity and specificity to interact with target molecules even superior to antibody. Accordingly, development of nanomaterials-based biosensors technology such as immunosensors and aptasensors against Aspergillus and Aspergillosis is of great significance and urgency. In this book chapter, we comprehensively introduce and analyze the recent progress of nanomaterials-based biosensors against Aspergillus and Aspergillosis. In addition, we reveal the challenges and provide our opinion in future opportunities for such sensing platform development. Ultimately, conclusion and future prospects are highlighted and summarized.